Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA2972 NenocorilantSummary: Nenocorilant is an orally effective glucocorticoid receptor antagonist. -
BA2973 IndibulinSummary: Indibulin (ZIO301), an orally effective synthetic inhibitor with good anticancer activity and minimal neurotoxicity. -
BA2975 N-trans-FeruloyltyramineSummary: N-trans-Feruloyltyramine (N-feruloyltyramine) is an alkaloid that is a potent antioxidant. -
BA2976 TaraxerolSummary: Taraxerol is isolated from dandelion and has anti-inflammatory and anti-cancer properties. -
BA2977 YH-306Summary: YH-306 is an antitumor agent. -
BA2978 OR-1896Summary: OR-1896 is the active long-lived metabolite of Levosimendan. -
BA2979 KYP-2047Summary: KYP-2047 is a potent proline oligopeptidase inhibitor that crosses the blood-brain barrier. -
BA2980 MisetionamideSummary: Misetionamide is an orally available oxathiazine compound. -
BA2982 TricetinSummary: Tricetin is a potent competitive protein interaction (PPI) inhibitor. -
BA2983 BatabulinSummary: Batabulin (T138067) is an antitumor agent that covalently and selectively binds to a subset of beta-microtubule protein isoforms, thereby disrupting microtubule polymerization.


